+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatitis C Drug"

Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • March 2025
  • 208 Pages
  • Global
From
Hepatitis C Drug Market - Product Thumbnail Image

Hepatitis C Drug Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Hepatitis C Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis C Therapeutics: Competitive Landscape

  • Report
  • December 2024
  • 84 Pages
  • Global
From
From
Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
From
From
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • December 2021
  • 245 Pages
  • Global
From
From
Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Hepatitis C Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Hepatitis C Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
Loading Indicator

The Hepatitis C Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat the Hepatitis C virus, a contagious virus that can cause liver damage. These drugs are typically administered orally or intravenously and can be used to treat both acute and chronic infections. The drugs are designed to reduce the amount of virus in the body, reduce the risk of liver damage, and improve the quality of life for those infected. The Hepatitis C Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Janssen Pharmaceuticals. Other companies, such as Mylan, Cipla, and Natco Pharma, also offer treatments for the virus. Show Less Read more